West Nile Virus Effects: Clinical Manifestations and Complications
Most West Nile virus infections (approximately 75%) remain completely asymptomatic, while approximately 25% develop West Nile fever, and less than 1% progress to neuroinvasive disease with a 10% fatality rate and substantial long-term disability 1, 2.
Clinical Spectrum
Asymptomatic Infection
- The majority of infected individuals (approximately 75%) never develop symptoms
- More than 780,000 illnesses have likely occurred in the United States since 1999, though only a fraction were clinically recognized 1
West Nile Fever (25% of infections)
- Self-limited febrile illness
- Symptoms include fever, headache, myalgias, and fatigue
- Clinical severity varies greatly
- Symptoms may be prolonged, with fatigue, headache, and myalgias persisting for months 3
West Nile Neuroinvasive Disease (<1% of infections)
This is the most critical manifestation, carrying approximately 10% mortality and significant morbidity 1. The three primary neuroinvasive syndromes are:
1. Meningitis
- Generally favorable long-term outcome 3
- Cerebrospinal fluid invariably shows pleocytosis, with neutrophil predominance in up to half of patients 4
2. Encephalitis
- Highly variable clinical course with considerable long-term morbidity 1
- Common neurologic features include:
- Neuroimaging may show abnormalities in basal ganglia, thalamus, cerebellum, and brainstem, though many patients have normal studies 4
3. Acute Flaccid Paralysis/Poliomyelitis
- Approximately two-thirds of patients with paralysis remain with significant weakness in affected limbs 1
- This syndrome has the worst prognosis—patients with acute flaccid paralysis do not recover limb strength 3
- May present as progressive asymmetric quadriparesis with mixed upper and lower motor neuron signs 5
- Can mimic amyotrophic lateral sclerosis, requiring serologic testing for accurate diagnosis 5
Risk Factors for Severe Disease
Neuroinvasive disease is more prevalent in older persons and those with immunosuppression 2. Additional risk factors include:
- Advanced age
- Comorbidities
- Genetic susceptibility 6
Special Populations
Pregnancy
- One documented case of intrauterine transmission resulted in an infant with chorioretinitis and cystic destruction of cerebral tissue 7
- However, causal relationship between WNV and congenital abnormalities has not been definitively proven
- Screening of asymptomatic pregnant women is not recommended due to lack of specific treatment and poorly defined consequences 7
Long-Term Sequelae
Persistent neurological and functional sequelae are common and add substantially to disease burden 6:
- Cognitive deficits
- Persistent weakness
- Gait disorders
- Movement disorders
- Recovery may be prolonged and incomplete 4
Diagnostic Considerations
Diagnosis depends predominantly on detection of WNV-specific IgM antibodies in cerebrospinal fluid or serum 4. A critical caveat: some patients have persistent WNV IgM responses in serum and/or cerebrospinal fluid, which may require revision of current serodiagnostic criteria 4.
Treatment Reality
No proven antiviral therapy exists; treatment is entirely supportive 8, 1. Ribavirin showed potentially deleterious effects and is not recommended 8. Various experimental approaches including interferon-α, intravenous immunoglobulin, and monoclonal antibodies have shown inconclusive or mixed results 8, 6.
Epidemiologic Context
WNV is now endemic throughout the contiguous United States, with 16,196 neuroinvasive disease cases and 1,549 deaths reported since 1999 1. It is now the most common cause of epidemic viral encephalitis in the United States 4 and will remain a formidable clinical and public health problem for years to come 1.